Intense Beam Treatment Utilizing Lasers for Medical Purposes
Laser Light Therapy for Parkinson's: Breakthrough Trials by SYMBYX
SYMBYX, an Aussie med-tech powerhouse, has made waves in the treatment of Parkinson's disease with their innovative use of laser light therapy, stirring hope for those grappling with the debilitating condition.
Their first human trial demonstrated that this novel therapy significantly improved mobility, cognition, balance, sleep, motivation, and fine motor skills in participants. These remarkable results have been reinforced in a Sydney-based follow-up trial to be published in the Journal of Photomodulation, Photomedicine and Laser Surgery.
These trials pave the way for larger, placebo-controlled trials to consolidate the data, with two such trials set to kick off in Sydney and Canada, promise blooming for the Parkinson’s community—anticipated outcomes by April 2022.
Powered by proprietary super-pulsing technology, SYMBYX's lasers deliver optimal light therapy doses without generating heat. These non-invasive, pocket-friendly devices are painless to use and are of high-quality Swedish manufacture.
The laser therapy energizes cell mitochondria, aiding in the loss of cellular energy commonly experienced in Parkinson's. Dr. Wayne Markman, SYMBYX CEO, explains, "You might not know this, but your colon produces both dopamine and serotonin—the critical neurotransmitters for healthy brain function."
The gut is targeted through photobiomodulation, reducing inflammation and promoting short-chain fatty acid metabolism. This, in turn, boosts dopamine and serotonin production, offering therapeutic benefits to Parkinson's patients.
Adelaide's proof-of-concept trial involved 12 Parkinson's patients, half of whom received 12 weeks of transcranial, neck, and abdominal laser therapy in a clinical setting, followed by home treatment. The remaining half were waitlisted for 14 weeks before commencing the same treatment.
All participants showed improvement in Parkinson's clinical signs, such as functional mobility, fine motor skills, and cognition. These improvements continued as long as the treatment did—a rarity in a neurodegenerative disease where decline is typically anticipated. No participant experienced significant decline over the year.
This trial is believed to be the first to explore photobiomodulation for targeting the gut-brain axis in Parkinson's. While small trials and case studies are underway examining transcranial photobiomodulation for Parkinson's, SYMBYX will continue to fund research endeavors, aiming to further substantiate and expand the therapeutic potential of this innovative light therapy.
[1] SYMBYX research summaries and patient testimonials[2] The PDCare Laser: an ARTG-listed and MDD-compliant medical device[3] Positive effects on brain health and chronic pain in Parkinson’s patients[4] Ongoing and future clinical trials[5] Expanding research collaborations, including international trials
- The cutting-edge laser light therapy developed by SYMBYX, a renowned med-tech company, shows promise for managing not just Parkinson's, but potentially other chronic diseases and medical conditions, as it aimed to fund more research endeavors.
- The unique super-pulsing technology used by SYMBYX in their laser devices not only enhances the delivery of light therapy for Parkinson's but also has potential implications for health and wellness, mental health, and even neurological disorders, as it boosts dopamine and serotonin production in the gut.
- The first-of-its-kind trial carried out by SYMBYX in Adelaide revealed that transcranial, neck, and abdominal laser therapy improved functional mobility, fine motor skills, and cognition in patients with Parkinson's, providing evidence for the application of this therapy for chronic diseases and fitness and exercise.
- The ongoing research at SYMBYX includes testing the effects of their innovations on brain health, chronic pain, and mental health, as well as funding collaborative international trials, aiming to further validate and expand the scope of laser light therapy's therapeutic potential in health and wellness, fitness and exercise, and neurological disorders.
